medroxyprogesterone has been researched along with Menopause in 202 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 134 (66.34) | 18.7374 |
| 1990's | 48 (23.76) | 18.2507 |
| 2000's | 17 (8.42) | 29.6817 |
| 2010's | 3 (1.49) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lai, JT; Liu, CL; Liu, TC | 1 |
| Jiang, X; Li, X; Luo, Y; Neapolitan, R; Wells, A; Zeng, Z | 1 |
| Khaleghinezhad, K; Menati, L; Siahpoosh, A; Tadayon, M | 1 |
| Barrett-Connor, E; Crandall, CJ; Greendale, GA; Guan, M; Ingles, SA; Laughlin, GA; Stanczyk, FZ; Ursin, GA | 1 |
| Hampton, T | 1 |
| CRAIG, JM; KISTNER, RW; STEINER, GJ | 1 |
| He, FF; Hui, Y; Wei, J; Wu, YY; Yin, CX; Yu, J; Yu, Q | 1 |
| Azoulay, C | 1 |
| Chang, SP; Chen, YJ; Wang, HL; Yang, TS; Yuan, CC | 1 |
| Aytan, H; Kelekci, S; Mollamahmutoglu, L; Oguz, S; Sargin, A; Tapisiz, OL | 1 |
| Battaglia, C; De Aloysio, D; Genazzani, AD; Mancini, F; Persico, N; Volpe, A | 1 |
| Ohkura, T | 1 |
| Nozaki, M | 1 |
| Ramsey-Goldman, R | 1 |
| Bastert, G; Michel, RT | 1 |
| Abe, O; Enomoto, K; Izuo, M; Kubo, K; Nomura, Y; Takatani, O; Tominaga, T | 1 |
| Boschitsch, E; Gitsch, E; Spona, J | 1 |
| Ingle, JN | 1 |
| Grönroos, M; Johansson, R; Kangas, L; Mäenpää, J; Nieminen, AL; Vanharanta, R | 1 |
| Alberto, P; Cavalli, F; Goldhirsch, A; Jungi, F; Martz, G | 1 |
| Friedrich, ER; Meyer, JS | 1 |
| Buhi, WC; Dougherty, MC; Notelovitz, M; Ware, MD | 1 |
| Flowers, CE; Hyde, BM; Wilborn, WH | 1 |
| Dougherty, MC; Gudat, JC; Notelovitz, M; Ware, MD | 1 |
| Graziottin, A; Marchetti, M; Onnis, A | 1 |
| Bottari, SP; Kaivez, E; Lescrainier, JP; Vauquelin, GP; Vokaer, A | 1 |
| Maggino, T; Marchesoni, D; Mozzanega, B | 1 |
| Lobo, RA; McCormick, W; Roy, S; Singer, F | 1 |
| Doorenbos, H; Pratt, JJ; Sleijfer, DT; Sluiter, WJ; van Veelen, H; Willemse, PH | 1 |
| Castaneda, TA; Gambrell, RD; Massey, FM; Ricci, CA; Ugenas, AJ; Wright, JM | 1 |
| Fernández-Aparicio, MA; Medina, M; Pérez-Palacios, G; Ulloa-Aguirre, A; Zacarías-Villareal, J | 1 |
| Lammintausta, R; Punnonen, R; Viinamäki, O | 1 |
| Chávez, B; Escobar, N; Larrea, F; Lince, M; Pérez, AE; Pérez-Palacios, G; Vilchis, F | 1 |
| Baulieu, EE; Binart, N; Catelli, MG; George, M; Gravanis, A; Laval, C; Robel, P; Roger-Jallais, L | 1 |
| Cramer, D; Ryan, KJ; Schiff, I; Tulchinsky, D | 1 |
| Backas, NE; Laatikainen, T; Pesonen, K; Stenman, UH; Vesterinen, E | 1 |
| Akerlund, M; Forsling, ML; Strömberg, P | 1 |
| Daenfeldt, JL; Løber, J; Mouridsen, HT; Palshof, T; Rose, C; Thorpe, SM | 1 |
| Mouridsen, HT; Palshof, T; Rose, C | 1 |
| Løber, J; Mouridsen, HT; Rose, C; Salimtschik, M | 1 |
| Brenner, PF | 1 |
| Carlson, HE; Chang, RJ; Davidson, BJ; Judd, HL | 1 |
| Davidson, BJ; Erlik, Y; Judd, HL; Mandel, FP; Meldrum, DR | 1 |
| Andor, J; Schneider, P; Tscherne, K; Vögelin, E; Wyss, H | 1 |
| Kalkhoff, RK; Kim, HJ; Marshall, WP; Morrow, PG | 1 |
| Block, AJ; Boysen, PG; Cantor, B; Lindsey, S; Martin, C; Wynne, JW | 1 |
| Hirvonen, E; Mälkönen, M; Manninen, V | 1 |
| Cantatore, FP; Carrozzo, M; Ingrosso, AM; Lacanna, R; Loverro, G; Sassanelli, E; Selvaggi, L | 1 |
| Burke, L; Golden, L; Wysowski, DK | 1 |
| Johnson, SH; Olsson, SE; Svensson, LO | 1 |
| Albisetti, W; Barbacini, P; Brincat, M; Crossignani, PG; Meschia, M | 1 |
| Hippeläinen, M; Hulkko, S; Karppinen, K; Kupari, M; Ventilä, M; Voutilainen, S | 1 |
| De Souza, MJ; Halvorson, CV; Luciano, AA; Nulsen, JC; Roy, MP; Schoenfeld, MJ | 1 |
| Aoki, T; Fukatsu, T; Kaba, S | 1 |
| Keefe, DL; Naftolin, F; Watson, R | 1 |
| Windler, E | 1 |
| Koval'chuk, NV; Metel'skaya, VA; Olfer'ev, AM; Petrichenko, IE; Popkov, SA; Shchukina, GN | 1 |
| Cagnacci, A; Facchinetti, F; Granella, F; Nappi, RE; Piccinini, F; Polatti, F | 1 |
| Grotowski, W; Halerz-Nowakowska, B; Warenik-Szymankiewicz, A; Wiza, M | 1 |
| Ciesielska-Kopacz, N; Kajdaniuk, D; Kos-Kudła, B; Kudła, M; Marek, B; Ostrowska, Z | 1 |
| Ascaso, JF; Cano, A; Carmena, R; Peiró, S; Real, JT; Tolosa, M | 1 |
| Cohen, LS; Groninger, H; Joffe, H; Nonacs, R; Soares, C; Soares, CN | 1 |
| Fried, G | 1 |
| Beckman, EM; Nachtigall, LE; Nachtigall, RD; Nachtigall, RH | 1 |
| Epstein, J; Nachtigall, LE; Szlachter, BN; Weiss, G; Young, BK | 1 |
| Beard, RJ; Campbell, S; McQueen, J; Minardi, J; Whitehead, MI | 1 |
| Alberto, P; Brunner, KW; Martz, G; Maurice, P; Obrecht, P; Senn, HJ; Sonntag, RW | 1 |
| Daehnfeldt, JL; Ellemann, K; Mattsson, W; Mouridsen, HT; Palshof, T; Rose, C | 1 |
| Pannuti, F | 2 |
| Daehnfeldt, J; Ellemann, K; Mattsson, W; Mouridsen, HT; Palshof, T; Rose, C | 1 |
| Ehrhardt, AA | 1 |
| de Larios, NM; Rubio Lotvin, B; Ruiz Moreno, JA | 1 |
| de Lima, GR; França, LC; Grabert, H; Miyada, CC; Vivas, AD | 1 |
| Rademaker, B; Schwarz, F; Thijssen, JH; van Kammen, E | 1 |
| Bullock, JL; Gambrell, RD; Massey, FM | 1 |
| Bennink, HJ; Haspels, AA; Schreurs, WH; Van Keep, PA | 1 |
| Hirte, WE; Klaassen, DJ; Rapp, EF | 1 |
| Chambers, HM; Kirkgard, Y; MacLennan, A; MacLennan, AH; O'Neill, S; Wenzel, S | 1 |
| Berger, BM; Berger, MJ; Brown, EM; Curtis, K; el-Hajj Fuleihan, G; Gleason, R; LeBoff, MS | 1 |
| Lundgren, S | 1 |
| Katoh, T; Kawahara, T; Kobayakawa, K; Takatsuka, Y; Tsumura, I | 1 |
| Bertolli, V; Boschetti, C; Cortellaro, M; Della Volpe, A; Nencioni, T; Zanussi, C | 1 |
| Byyny, RL; Hiatt, WR; Moore, LG; Pickett, CK; Regensteiner, JG; Woodard, WD | 1 |
| Karlberg, J; Wiklund, I | 1 |
| Abelli, P; Boschetti, C; Buzzi, F; Caraceni, MP; Cortellaro, M; Francucci, B; Nencioni, T; Ortolani, S; Polvani, F; Zanussi, C | 1 |
| Crosignani, P; Fumagalli, R; Gaubatz, J; Ghanem, K; Maini, MC; Meschia, M; Morrisett, JD; Paoletti, R; Soma, M | 1 |
| Anderson, DC; Buckler, HM; Burger, HG; Evans, CA; Mamtora, H | 1 |
| Bellantoni, MF; Blackman, MR; Cho, DE; Harman, SM | 1 |
| Canova, N; Longhi, A; Martoni, A; Pannuti, F | 1 |
| Christiansen, C; Haarbo, J; Hassager, C; Jensen, SB; Riis, BJ | 1 |
| Houjou, T; Kadota, K; Mori, N; Wada, T; Watatani, M; Yasutomi, M | 1 |
| Byrjalsen, I; Thormann, L | 1 |
| Braly, PS; Feldesman, MR; Gosink, BB; Lin, MC; Pretorius, DH; Stuenkel, CA; Wolf, SI | 1 |
| Ames, R; Cundy, T; Evans, M; Reid, IR; Roberts, H; Wattie, D | 1 |
| Heikkinen, J; Kurttila-Matero, E; Kyllönen, E; Takala, T; Väänänen, HK; Vuori, J | 1 |
| Bellantoni, MF; Blackman, MR; Cullins, VE; Engelhardt, SM; Harman, SM | 1 |
| Confino-Cohen, R; Lang, R; Lishner, M; Ravid, M; Savin, H | 1 |
| Bologna, A; Dal Magro, L; Dal Pozzo, M; Fiscon, D; Marchesoni, D; Mozzanega, B | 1 |
| Clisham, PR; de Ziegler, D; Judd, HL; Lozano, K | 1 |
| LaRosa, JC; Miller, VT; Muesing, RA; Phillips, EA; Stillman, RJ; Stoy, DB | 1 |
| Sherwin, BB | 1 |
| Gallagher, JC; Goldgar, D; Kable, WT | 1 |
| Cano, A; Fernandes, H; Mahiques, P; Serrano, S | 1 |
| Mishell, DR; Moyer, DL; Page, MA; Roy, S; Shoupe, D | 1 |
| Meyer, JE; Ravnikar, VA; Stomper, PC; Van Voorhis, BJ | 1 |
| Imaoka, S; Inaji, H; Koyama, H; Noguchi, S; Yamamoto, H | 2 |
| Biakhov, MIu; Meshcheriakova, NG; Vasiuta, NIu; Voznyĭ, EK | 1 |
| King, RJ; Lane, G; Whitehead, MI | 1 |
| Doihara, H; Kurita, A; Moriwaki, S; Saeki, H; Soga, H; Takashima, S; Takiyama, W; Tanada, M; Yokoyama, N | 1 |
| Feng, DD; Ge, QS; Lin, SQ; Wang, HL; Yao, FY | 1 |
| Cauley, J; Egeland, GM; Guzick, D; Kelsey, SF; Kuller, LH; Matthews, KA | 1 |
| Friedl, KE; Hannan, CJ; Plymate, SR; Stone, IK; Wright, JR; Yancey, MK | 1 |
| Aakvaag, A; Kvinnsland, S; Lundgren, S; Lønning, PE | 1 |
| Bewtra, C; Gallagher, JC; Weinstein, L | 1 |
| Haddock, DA | 1 |
| Jensen, HK; Pedersen, OD | 1 |
| Avioli, LV; McCracken, R; McMurtry, C; Pacifici, R; Peck, WA; Rifas, L; Vered, I | 1 |
| Becher, R; Gerhold, U; Hirche, H; Höffken, K; Miller, AA; Schmidt, CG | 1 |
| Deligdisch, L; Goodman, HM; Kredentser, D | 1 |
| Donát, J; Reslová, T | 1 |
| Buzdar, AU; Fritsche, HA; Holmes, FA; Hortobagyi, GN; Hug, V; Kau, SW | 1 |
| Mouridsen, HT | 1 |
| Burnett, LS; Hargrove, JT; Maxson, WS; Wentz, AC | 1 |
| Bender, PR; Hagerman, DD; Moore, LG; Pickett, CK; Regensteiner, JG; Weil, JV; Woodard, WD | 1 |
| Hagerman, DD; Moore, LG; Pickett, CK; Regensteiner, JG; Weil, JV; Woodard, WD | 1 |
| Ferenczy, A; Gelfand, MM | 1 |
| Adami, S; Bertoldo, F; Lo Cascio, V; Maresca, V; Residori, M; Rossini, M; Suppi, R | 1 |
| Bolognia, JL; Braverman, IM; Rousseau, ME; Sarrel, PM | 1 |
| Namer, M | 1 |
| Carleo, J; Hendrix, JW; Luciano, AA; Turksoy, RN | 1 |
| Aksel, S; Prough, SG; Shepherd, J; Wiebe, RH | 1 |
| Alfthan, H; Seppälä, M; Stenman, UH; Vartiainen, E | 1 |
| Bewtra, C; Gallagher, JC; Kable, WT | 1 |
| Figueroa-Casas, PR; Schlaen, I | 1 |
| Bush, TL; Ernster, VL; Huggins, GR; Hulka, BS; Kelsey, JL; Schottenfeld, D | 1 |
| Abe, O; Enomoto, K; Izuo, M; Kubo, K; Nomura, Y; Takatani, O; Tominaga, T; Yoshida, M | 1 |
| Elder, MG; Philipson, KA; White, JO | 1 |
| Bonte, J; Ide, P; Janssens, JP | 1 |
| Grant, B; Marcus, R; Minkoff, JR; Young, G | 1 |
| Schweitzer, MJ; Sleijfer, DT; Tjabbes, T; van Veelen, H; Willemse, PH | 1 |
| Fotherby, K | 1 |
| Blossey, HC; Kleeberg, U; Nagel, GA; Wander, HE | 1 |
| King, RJ; Whitehead, MI | 1 |
| Manni, A | 1 |
| Dowsett, M; Jeffcoate, SL; Lal, A; Smith, IE | 1 |
| Hellberg, D; Nilsson, S | 1 |
| Hirvonen, E; Kärkkäinen, J; Lipasti, A; Mälkönen, M; Manninen, V; Nuntila, J; Timonen, H | 1 |
| Carlson, RW; Hannigan, JF; Hendrickson, C; Kohler, M; McWhirter, K; Tan, YO | 1 |
| Brema, F; Canobbio, L; Crivellari, D; Di Fronzo, G; Fassio, T; Galligioni, E; Gasparini, G; Monfardini, S; Talamini, R; Villalta, D | 1 |
| Baroni, M; Longhi, A; Martoni, A; Pannuti, F; Piana, E | 1 |
| Hisamatsu, K; Nomura, Y; Tashiro, H; Toi, M | 1 |
| Camaggi, CM; Cilenti, G; Fruet, F; Martoni, A; Pannuti, F | 1 |
| Barnes, RB; Lobo, RA; Roy, S | 1 |
| Cagnacci, A; Fioretti, P; Gambacciani, M; Mais, V; Melis, GB; Paoletti, AM; Petacchi, FD | 1 |
| Gibbons, WE; Lobo, RA; Mishell, DR; Moyer, DL; Roy, S | 1 |
| King, RJ; Lane, G; Pryse-Davies, J; Ryder, TA; Siddle, NC; Whitehead, MI | 1 |
| Dawood, MY; Khan-Dawood, FS; Ramos, J | 1 |
| Glick, JH; Haller, DG | 1 |
| Roof, BS | 1 |
| Eggertsen, R | 1 |
| Anderson, DC; Buckler, H; Mamtora, H; Petsos, P | 1 |
| Alapin-Rubillovitz, S; Casper, RF | 1 |
| Blijham, GH; Mellink, WA; Meulenberg, PM; Van Deijk, WA | 1 |
| Cremer, P; Kruse, B; Kuhn, W; Nagel, GA; Seidel, D; Teichmann, AT; Wander, HE; Wieland, H | 1 |
| Miura, S; Murai, H; Yoshida, M | 1 |
| Farabegoli, G; Martoni, A; Pannuti, F; Piana, E | 1 |
| Bryman, I; Ivarsson, E; Samsioe, G | 1 |
| Adams, JS; Endres, DB; Lobo, RA; Roy, S; Rude, RK; Shoupe, D; Singer, FR | 1 |
| Alfthan, H; Jalkanen, J; Ranta, T; Seppälä, M; Stenman, UH; Vartiainen, E | 1 |
| Weinstein, L | 1 |
| Kamby, C; Rose, C | 1 |
| Beex, L; Boetius, G; Breed, W; Burghouts, J; Doesburg, W; Hillen, H; Holdrinet, A; Hoogendoorn, G; van Turnhout, J; Verhulst, M | 1 |
| Alghisi, A; Marini, G; Marinone, G; Marpicati, P; Roncoli, B; Simoncini, E; Zaniboni, A | 1 |
| Alberto, P; Barrelet, L; Cavalli, F; Goldhirsch, A; Jungi, F; Kaplan, E; Martz, G; Mermillod, B; Obrecht, JP | 1 |
| Alonso, MC; Avella, A; Beltrán, M; Borrás, J; Bosch, FX; Ojeda, B; Viladiu, P | 1 |
| Johansson, BG; Ottosson, UB; von Schoultz, B | 1 |
| Ramont, CB | 1 |
| Copenhaver, EH | 1 |
| Ambrosini, A; Gentile, D; Minucci, D; Pelusi, G | 1 |
| Taleghany, P | 1 |
| Broverman, DM; Hall, F; Klaiber, EL; Kobayashi, Y | 1 |
| Brar, HK; Lin, TJ; Roblete, BV; So-Bosita, JL | 1 |
| Zussman, L | 1 |
| Ayalon, D; Ravid, R | 1 |
| Huffman, JW | 1 |
| Rhoades, FP | 1 |
| Gross, MA; Schalch, DS; Wise, AJ | 1 |
| Hellema, M; Nilsson, L; Patek, E | 1 |
| Judd, HL; Lucas, WE; Yen, SS | 1 |
| Campagnoli, C; Capra, A; Massobrio, M | 1 |
| Lohrenz, FN | 1 |
| Moggian, G; Tamburini, E | 1 |
| Scott, MM | 1 |
| Ober, WB; Roland, M; Stubbs, S | 1 |
| Cali, RW | 1 |
| Samaja, BA | 1 |
| Marchant, DJ | 1 |
| Goisis, M | 1 |
| Lévy, G; Muller, P | 1 |
| Alfieri, G | 1 |
11 review(s) available for medroxyprogesterone and Menopause
| Article | Year |
|---|---|
[Menopause in 2004: "hormone replacement therapy" is not what it used to be anymore].
Topics: Breast Neoplasms; Clinical Trials as Topic; Equilin; Estrogen Replacement Therapy; Female; Hot Flashes; Humans; Life Style; Medroxyprogesterone; Menopause; Myocardial Infarction; Phytoestrogens; Risk Assessment; Thromboembolism; Treatment Outcome | 2004 |
[Cognitive impairment].
Topics: Alzheimer Disease; Cholinesterase Inhibitors; Clinical Trials as Topic; Donepezil; Drug Therapy, Combination; Estrogen Replacement Therapy; Estrogens; Female; Humans; Indans; Male; Medroxyprogesterone; Menopause; Mental Status Schedule; Piperidines; Prognosis; Risk Factors; Sex Factors | 2006 |
[Hormone replacement therapy].
Topics: Autonomic Nervous System Diseases; Breast Neoplasms; Estrogen Replacement Therapy; Estrogens; Female; Hormone Replacement Therapy; Hot Flashes; Humans; Medroxyprogesterone; Menopause; Receptors, Estrogen; Risk; Selective Estrogen Receptor Modulators; Syndrome | 2006 |
Therapeutic effect of tamoxifen related to estrogen receptor level.
Topics: Adult; Aged; Breast Neoplasms; Clinical Trials as Topic; Diethylstilbestrol; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Medroxyprogesterone; Menopause; Middle Aged; Neoplasm Metastasis; Receptors, Estrogen; Remission, Spontaneous; Tamoxifen | 1980 |
Treatment of advanced breast cancer with progestins.
Topics: Age Factors; Animals; Breast Neoplasms; Clinical Trials as Topic; Dose-Response Relationship, Drug; Female; Humans; Medroxyprogesterone; Menopause; Middle Aged; Progestins; Receptors, Estrogen | 1981 |
Modification of serum lipids and cardiovascular risk by estrogenic active compounds.
Topics: Aged; Cardiovascular Diseases; Cholesterol, HDL; Cholesterol, LDL; Estrogens, Conjugated (USP); Female; Hormone Replacement Therapy; Humans; Hyperlipidemias; Medroxyprogesterone; Menopause; Middle Aged; Risk Factors; Selective Estrogen Receptor Modulators | 1999 |
Progestins in breast cancer treatment. A review.
Topics: Breast Neoplasms; Clinical Trials as Topic; Drug Therapy, Combination; Estrogens; Female; Growth Substances; Humans; Medroxyprogesterone; Megestrol; Menopause | 1992 |
Endometrial thickness after menopause: effect of hormone replacement.
Topics: Biopsy; Dilatation and Curettage; Endometrium; Estrogen Replacement Therapy; Estrogens; Female; Follow-Up Studies; Humans; Hyperplasia; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Time Factors; Ultrasonography | 1991 |
Benefits and risks of menopausal estrogen and/or progestin hormone use.
Topics: Breast Neoplasms; Coronary Disease; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Osteoporosis; Progesterone Congeners; Risk Factors; Uterine Neoplasms | 1988 |
Tamoxifen therapy of metastatic breast cancer.
Topics: Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma; Clinical Trials as Topic; Female; Humans; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Neoplasm Metastasis; Random Allocation; Tamoxifen | 1987 |
[On the hormonal treatment of the menopause].
Topics: Ethinyl Estradiol; Female; Humans; Medroxyprogesterone; Menopause | 1967 |
72 trial(s) available for medroxyprogesterone and Menopause
| Article | Year |
|---|---|
Evaluation of contextual and demographic factors on licorice effects on reducing hot flashes in postmenopause women.
Topics: Contraceptives, Oral, Synthetic; Double-Blind Method; Estrogens, Conjugated (USP); Female; Glycyrrhiza; Hormone Replacement Therapy; Hot Flashes; Humans; Medroxyprogesterone; Menopause; Middle Aged; Phytotherapy; Postmenopause; Severity of Illness Index; Socioeconomic Factors; Treatment Outcome | 2014 |
Increases in serum estrone sulfate level are associated with increased mammographic density during menopausal hormone therapy.
Topics: Biomarkers, Tumor; Breast Neoplasms; Contraceptives, Oral, Synthetic; Drug Therapy, Combination; Estrogens; Estrogens, Conjugated (USP); Estrone; Female; Follow-Up Studies; Hormone Replacement Therapy; Humans; Incidence; Mammography; Medroxyprogesterone; Menopause; Middle Aged; Progesterone; Progestins; Radioimmunoassay; Risk Factors; Surveys and Questionnaires; United States | 2008 |
[Comparison of the effect of fluoxetine combined with hormone replacement therapy (HRT) and single HRT in treating menopausal depression].
Topics: Adult; Climacteric; Depressive Disorder; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Fluoxetine; Humans; Medroxyprogesterone; Menopause; Middle Aged | 2004 |
Effect of continuous administration of conjugated estrogen plus medroxyprogesterone acetate (Premelle) in postmenopausal women in Taiwan.
Topics: Cholesterol, HDL; Cholesterol, LDL; Contraceptives, Oral, Synthetic; Double-Blind Method; Estrogens; Estrogens, Conjugated (USP); Female; Follow-Up Studies; Humans; Medroxyprogesterone; Menopause; Middle Aged; Outpatients; Pharyngitis; Postmenopause; Sexual Behavior; Taiwan; Time Factors; Triglycerides | 2004 |
The role of hormone replacement therapy in endometrial polyp formation.
Topics: Adult; Contraceptives, Oral, Synthetic; Double-Blind Method; Endometrium; Estradiol; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Estrogens; Estrogens, Conjugated (USP); Female; Humans; Hysteroscopy; Medroxyprogesterone; Menopause; Middle Aged; Norethindrone; Norpregnenes; Obesity; Polyps; Prospective Studies; Recurrence; Regression Analysis | 2005 |
Does hormone replacement therapy affect disease activity in patients with systemic lupus erythematosus?
Topics: Biomarkers; Double-Blind Method; Drug Therapy, Combination; Estrogen Replacement Therapy; Estrogens; Estrogens, Conjugated (USP); Female; Follicle Stimulating Hormone; Follow-Up Studies; Humans; Lupus Erythematosus, Systemic; Medroxyprogesterone; Menopause; Severity of Illness Index; Treatment Outcome | 2005 |
[Therapy of the surgical menopause syndrome with depot medroxyprogesterone acetate and its objective evaluation testing the reaction of the anterior pituitary gland to stimulation with gonadotropin-releasing hormone].
Topics: Adult; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Menopause, Premature; Middle Aged; Pituitary Gland, Anterior; Pituitary Hormone-Releasing Hormones; Placebos | 1983 |
Additive hormonal therapy in women with advanced breast cancer.
Topics: Aminoglutethimide; Androgens; Breast Neoplasms; Clinical Trials as Topic; Danazol; Drug Therapy, Combination; Estrogens; Female; Gonadal Steroid Hormones; Gonadotropin-Releasing Hormone; Humans; Hypophysectomy; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Random Allocation; Tamoxifen | 1984 |
Randomized trial of low- versus high-dose medroxyprogesterone acetate in the induction treatment of postmenopausal patients with advanced breast cancer.
Topics: Age Factors; Antineoplastic Agents; Breast Neoplasms; Clinical Trials as Topic; Drug Administration Schedule; Female; Humans; Injections, Intramuscular; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Random Allocation; Time Factors | 1984 |
Oral medroxyprogesterone in the treatment of postmenopausal symptoms.
Topics: Administration, Oral; Adolescent; Adult; Aged; Castration; Climacteric; Clinical Trials as Topic; Double-Blind Method; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Medroxyprogesterone; Menopause; Middle Aged; Prolactin | 1980 |
Therapeutic effect of tamoxifen related to estrogen receptor level.
Topics: Adult; Aged; Breast Neoplasms; Clinical Trials as Topic; Diethylstilbestrol; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Medroxyprogesterone; Menopause; Middle Aged; Neoplasm Metastasis; Receptors, Estrogen; Remission, Spontaneous; Tamoxifen | 1980 |
Therapeutic effect of tamoxifen alone versus tamoxifen in combination wtih gestagen and oestrogen in advanced breast cancer.
Topics: Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Clinical Trials as Topic; Diethylstilbestrol; Drug Interactions; Drug Therapy, Combination; Female; Humans; Medroxyprogesterone; Menopause; Middle Aged; Receptors, Estrogen; Remission, Spontaneous; Tamoxifen | 1980 |
Treatment of advanced breast cancer with progestins.
Topics: Age Factors; Animals; Breast Neoplasms; Clinical Trials as Topic; Dose-Response Relationship, Drug; Female; Humans; Medroxyprogesterone; Menopause; Middle Aged; Progestins; Receptors, Estrogen | 1981 |
Menopause, medroxyprogesterone and breathing during sleep.
Topics: Adult; Age Factors; Aged; Double-Blind Method; Electroencephalography; Female; Humans; Medroxyprogesterone; Menopause; Middle Aged; Oxygen; Placebos; Progesterone; Random Allocation; Sleep Apnea Syndromes | 1981 |
Effect of oestrogen replacement on bone metabolism and cytokines in surgical menopause.
Topics: Adult; Alkaline Phosphatase; Amino Acids; Bone and Bones; Bone Remodeling; Drug Therapy, Combination; Estradiol; Estrogen Replacement Therapy; Female; Humans; Hysterectomy; Interleukin-2; Interleukin-6; Medroxyprogesterone; Menopause; Middle Aged; Osteoporosis, Postmenopausal; Ovariectomy; Parathyroid Hormone | 1995 |
Plasma concentrations of medroxyprogesterone acetate, estradiol and estrone following oral administration of Klimaxil, Trisequence/Provera and Divina. A randomized, single-blind, triple cross-over bioavailability study in menopausal women.
Topics: Administration, Oral; Biological Availability; Drug Combinations; Estradiol; Estrogen Replacement Therapy; Estrone; Female; Hormones; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Reference Values; Single-Blind Method | 1994 |
A clinical trial on the effects of a combination of elcatonin (carbocalcitonin) and conjugated estrogens on vertebral bone mass in early postmenopausal women.
Topics: Administration, Oral; Analysis of Variance; Biomarkers; Bone Density; Calcitonin; Drug Synergism; Drug Therapy, Combination; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone; Menopause; Osteoporosis, Postmenopausal; Spine | 1993 |
Evaluation of low-dose estrogen and progestin therapy in postmenopausal women. A double-blind, prospective study of sequential versus continuous therapy.
Topics: Analysis of Variance; Bone Density; Cholesterol; Double-Blind Method; Drug Therapy, Combination; Endometrium; Estrogen Replacement Therapy; Estrogens; Female; Humans; Lipoproteins, HDL; Lipoproteins, LDL; Longitudinal Studies; Medroxyprogesterone; Menopause; Middle Aged; Prospective Studies; Triglycerides | 1993 |
Hormone replacement therapy may alleviate sleep apnea in menopausal women: a pilot study.
Topics: Aged; Drug Combinations; Estradiol; Female; Follow-Up Studies; Hormone Replacement Therapy; Humans; Medroxyprogesterone; Menopause; Middle Aged; Pilot Projects; Polysomnography; Progesterone Congeners; Sleep Apnea Syndromes; Treatment Outcome | 1999 |
Course of primary headaches during hormone replacement therapy.
Topics: Administration, Cutaneous; Administration, Oral; Estradiol; Estrogens, Conjugated (USP); Female; Hormone Replacement Therapy; Humans; Medroxyprogesterone; Menopause; Middle Aged; Migraine without Aura; Prospective Studies; Severity of Illness Index; Tension-Type Headache; Treatment Outcome | 2001 |
[Clinical evaluation of Divina in treatment of hormonal disturbances in women].
Topics: Adult; Blood Glucose; Cardiovascular Diseases; Drug Combinations; Estradiol; Estrogen Replacement Therapy; Female; Glucose Tolerance Test; Humans; Kidney; Lipid Metabolism; Liver; Medroxyprogesterone; Menopause; Menstruation Disturbances; Middle Aged; Osteoporosis, Postmenopausal | 2001 |
An open trial of mirtazapine in menopausal women with depression unresponsive to estrogen replacement therapy.
Topics: Adult; Antidepressive Agents; Depression; Estradiol; Female; Hormone Replacement Therapy; Humans; Medroxyprogesterone; Menopause; Mianserin; Middle Aged; Mirtazapine; Treatment Outcome | 2001 |
Estrogen replacement therapy I: a 10-year prospective study in the relationship to osteoporosis.
Topics: Clinical Trials as Topic; Double-Blind Method; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone; Menopause; Osteoporosis; Prospective Studies; Time Factors | 1979 |
Combined chemo- and hormonal therapy in advanced breast cancer.
Topics: Antineoplastic Agents; Breast Neoplasms; Castration; Chlorambucil; Clinical Trials as Topic; Cyclophosphamide; Diethylstilbestrol; Doxorubicin; Drug Therapy, Combination; Female; Fluorouracil; Humans; Medroxyprogesterone; Menopause; Methotrexate; Middle Aged; Neoplasm Metastasis; Prednisone; Vincristine | 1977 |
Therapeutic effect of tamoxifen versus tamoxifen combined with medroxyprogesterone acetate in advanced breast cancer in postmenopausal women.
Topics: Adult; Aged; Breast Neoplasms; Clinical Trials as Topic; Drug Therapy, Combination; Female; Humans; Medroxyprogesterone; Menopause; Middle Aged; Receptors, Estrogen; Remission, Spontaneous; Tamoxifen; Time Factors | 1979 |
[Endocrine treatment of metastasizing breast cancer in menopausal women. A randomized comparison between tamoxifen (Nolvadex) versus tamoxifen and medroxyprogesterone acetate (Clinovir)].
Topics: Aged; Breast Neoplasms; Drug Therapy, Combination; Evaluation Studies as Topic; Female; Humans; Medroxyprogesterone; Menopause; Middle Aged; Neoplasm Metastasis; Random Allocation; Remission, Spontaneous; Tamoxifen | 1979 |
Use of medroxyprogesterone acetate to prevent menopausal symptoms.
Topics: Adult; Breast Neoplasms; Castration; Climacteric; Drug Evaluation; Estrogens; Female; Follicle Stimulating Hormone; Humans; Injections, Intramuscular; Luteinizing Hormone; Medroxyprogesterone; Menopause; Middle Aged; Placebos; Radioimmunoassay; Uterine Neoplasms | 1975 |
Response to medroxyprogesterone acetate (NSC-26386) as secondary hormone therapy for metastatic breast cancer in postmenopausal women.
Topics: Administration, Oral; Androgens; Brain Neoplasms; Breast Neoplasms; Drug Evaluation; Dyspnea; Estrogens; Female; Humans; Injections, Intramuscular; Lung Neoplasms; Medroxyprogesterone; Menopause; Middle Aged; Neoplasm Metastasis; Remission, Spontaneous | 1976 |
Oestrogen and cyclical progestogen in postmenopausal hormone replacement therapy.
Topics: Adult; Aged; Blood Pressure; Body Weight; Delayed-Action Preparations; Endometrium; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Lipids; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Menstruation; Middle Aged; Prospective Studies | 1992 |
Effect of sequential and daily continuous hormone replacement therapy on indexes of mineral metabolism.
Topics: Bone Density; Delayed-Action Preparations; Drug Administration Schedule; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Prospective Studies | 1992 |
Short- and long-term effects of hormone replacement therapy (transdermal estradiol vs oral conjugated equine estrogens, combined with medroxyprogesterone acetate) on blood coagulation factors in postmenopausal women.
Topics: Administration, Cutaneous; Administration, Oral; Blood Coagulation Factors; Drug Therapy, Combination; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Time Factors | 1991 |
Short-term effects of estrogen and progestin on blood pressure of normotensive postmenopausal women.
Topics: Blood Pressure; Drug Therapy, Combination; Estradiol; Estrogens, Conjugated (USP); Estrone; Female; Humans; Medroxyprogesterone; Menopause; Middle Aged; Progesterone; Radioimmunoassay; Single-Blind Method | 1991 |
Evaluation of quality of life in clinical trials. Selecting quality-of-life measures.
Topics: Administration, Cutaneous; Adult; Clinical Trials as Topic; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Estradiol; Female; Humans; Medroxyprogesterone; Menopause; Middle Aged; Quality of Life; Treatment Outcome | 1991 |
Cyclic hormonal replacement therapy after the menopause: transdermal versus oral treatment.
Topics: Administration, Cutaneous; Administration, Oral; Adult; Drug Therapy, Combination; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone; Menopause; Middle Aged | 1991 |
Plasma Lp(a) concentration after oestrogen and progestagen in postmenopausal women.
Topics: Estrogen Replacement Therapy; Estrogens; Evaluation Studies as Topic; Female; Humans; Lipoprotein(a); Lipoproteins; Medroxyprogesterone; Menopause; Middle Aged | 1991 |
Effects of progestin-opposed transdermal estrogen administration on growth hormone and insulin-like growth factor-I in postmenopausal women of different ages.
Topics: Aged; Aging; Body Mass Index; Estradiol; Estrogen Replacement Therapy; Estrone; Female; Growth Hormone; Humans; Insulin-Like Growth Factor I; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged | 1991 |
High-dose medroxyprogesterone acetate versus oophorectomy as first-line therapy of advanced breast cancer in premenopausal patients.
Topics: Adult; Antineoplastic Agents; Breast Neoplasms; Combined Modality Therapy; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Ovariectomy; Prospective Studies; Random Allocation; Survival Rate | 1991 |
Serum lipids, lipoproteins, and apolipoproteins during postmenopausal estrogen replacement therapy combined with either 19-nortestosterone derivatives or 17-hydroxyprogesterone derivatives.
Topics: Androgen Antagonists; Apolipoproteins; Cyproterone; Cyproterone Acetate; Desogestrel; Drug Therapy, Combination; Estradiol; Estrogen Replacement Therapy; Female; Humans; Levonorgestrel; Lipid Metabolism; Lipids; Lipoproteins; Medroxyprogesterone; Menopause; Middle Aged; Norgestrel; Norpregnenes | 1991 |
Transdermal estradiol with oral progestin: biological and clinical effects in younger and older postmenopausal women.
Topics: Administration, Cutaneous; Administration, Oral; Aged; Aging; Analysis of Variance; Body Mass Index; Body Weight; Delayed-Action Preparations; Double-Blind Method; Estradiol; Estrogen Replacement Therapy; Estrone; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Menstruation; Middle Aged; Placebos; Vagina | 1991 |
Comparison of continuous versus sequential estrogen and progestin therapy in postmenopausal women.
Topics: Drug Administration Schedule; Endometrium; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Lipoproteins; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Pilot Projects; Uterine Hemorrhage | 1991 |
Effects of conjugated equine estrogen with and without three different progestogens on lipoproteins, high-density lipoprotein subfractions, and apolipoprotein A-I.
Topics: Adult; Apolipoprotein A-I; Apolipoproteins A; Cholesterol; Cholesterol, HDL; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Lipoproteins; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Norgestrel; Sex Hormone-Binding Globulin | 1991 |
The impact of different doses of estrogen and progestin on mood and sexual behavior in postmenopausal women.
Topics: Affect; Estradiol; Estrogens, Conjugated (USP); Estrone; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Sexual Behavior; Testosterone | 1991 |
Effect of progestin therapy on cortical and trabecular bone: comparison with estrogen.
Topics: Bone Density; Cholesterol; Contraceptive Agents, Female; Drug Synergism; Drug Therapy, Combination; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Prospective Studies; Triglycerides | 1991 |
Effect of continuous oestradiol-medroxyprogesterone administration on plasma lipids and lipoproteins.
Topics: Adult; Drug Therapy, Combination; Estradiol; Estrogen Replacement Therapy; Female; Humans; Lipids; Lipoproteins; Medroxyprogesterone; Menopause; Middle Aged; Prospective Studies | 1991 |
Postmenopausal hormone replacement with a combination estrogen-progestin regimen for five days per week.
Topics: Adult; Biopsy; Drug Therapy, Combination; Endometrium; Estrogen Replacement Therapy; Estrogens; Female; Humans; Lipids; Medroxyprogesterone; Menopause; Middle Aged; Prospective Studies; Uterine Hemorrhage | 1991 |
Serum lipids and lipoproteins in continuous or cyclic medroxyprogesterone acetate treatment in postmenopausal women treated with conjugated estrogens.
Topics: Adult; Aged; Dose-Response Relationship, Drug; Estrogen Replacement Therapy; Estrogens; Female; Humans; Lipids; Lipoproteins; Medroxyprogesterone; Menopause; Middle Aged; Prospective Studies | 1990 |
[Transcutaneous estradiol treatment in the climacteric].
Topics: Administration, Cutaneous; Adult; Climacteric; Estradiol; Female; Humans; Medroxyprogesterone; Menopause; Middle Aged | 1990 |
How to improve adjuvant treatment results in postmenopausal patients.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Diphosphonates; Drug Therapy, Combination; Female; Fluorouracil; Follow-Up Studies; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Meta-Analysis as Topic; Methotrexate; Middle Aged; Prednisone; Randomized Controlled Trials as Topic; Retrospective Studies; Survival Rate; Tamoxifen; Vincristine | 1989 |
Combined effects of female hormones and metabolic rate on ventilatory drives in women.
Topics: Adult; Drug Interactions; Estrogens, Conjugated (USP); Female; Humans; Hypercapnia; Hypoxia; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Oxygen Consumption; Physical Exertion; Pregnancy; Respiration | 1989 |
Progestin and estrogen reduce sleep-disordered breathing in postmenopausal women.
Topics: Drug Combinations; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone; Menopause; Middle Aged; Respiration Disorders; Sleep Apnea Syndromes; Sleep Wake Disorders | 1989 |
A prospective 1-year study of estrogen and progestin in postmenopausal women: effects on the endometrium.
Topics: Drug Therapy, Combination; Endometrial Hyperplasia; Endometrium; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone; Menopause; Prospective Studies; Random Allocation; Uterine Hemorrhage; Uterine Neoplasms | 1989 |
Transdermal estradiol in the treatment of postmenopausal bone loss.
Topics: Administration, Cutaneous; Alkaline Phosphatase; Bone and Bones; Calcium; Clinical Trials as Topic; Drug Therapy, Combination; Estradiol; Female; Humans; Hydroxyproline; Medroxyprogesterone; Menopause; Middle Aged; Minerals; Osteoporosis; Parathyroid Hormone; Radionuclide Imaging; Random Allocation; Reference Values | 1989 |
Skin changes in menopause.
Topics: Adult; Aged; Biopsy; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Elastic Tissue; Estradiol; Estrogen Replacement Therapy; Female; Humans; Medroxyprogesterone; Menopause; Microscopy, Electron; Middle Aged; Sebum; Skin; Skin Aging; Skin Physiological Phenomena | 1989 |
Endometrial histology and bleeding patterns in menopausal women treated with estrogen and continuous or cyclic progestin.
Topics: Antineoplastic Agents; Biopsy; Double-Blind Method; Drug Therapy, Combination; Endometrium; Estrogens, Conjugated (USP); Female; Gonadotropins, Pituitary; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Prospective Studies; Random Allocation; Uterine Hemorrhage | 1988 |
A phase III trial of oral high-dose medroxyprogesterone acetate (MPA) versus mepitiostane in advanced postmenopausal breast cancer.
Topics: Adult; Androstanols; Breast Neoplasms; Clinical Trials as Topic; Double-Blind Method; Estrogen Antagonists; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Ovariectomy; Random Allocation | 1985 |
Oral high-dose medroxyprogesterone acetate versus tamoxifen. A randomized crossover trial in postmenopausal patients with advanced breast cancer.
Topics: Aged; Breast Neoplasms; Clinical Trials as Topic; Drug Administration Schedule; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Random Allocation; Tamoxifen | 1986 |
Tamoxifen therapy of metastatic breast cancer.
Topics: Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma; Clinical Trials as Topic; Female; Humans; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Neoplasm Metastasis; Random Allocation; Tamoxifen | 1987 |
Pilot study to evaluate a new regimen to treat climacteric complaints with cyclic combined oestradiol valerate/medroxyprogesterone acetate.
Topics: Adult; Climacteric; Clinical Trials as Topic; Drug Therapy, Combination; Estradiol; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Pilot Projects; Uterine Hemorrhage | 1987 |
Clinical and lipid metabolic effects of unopposed oestrogen and two oestrogen-progestogen regimens in post-menopausal women.
Topics: Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Drug Therapy, Combination; Estradiol; Female; Humans; Levonorgestrel; Lipids; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Norgestrel; Triglycerides | 1987 |
Adjuvant therapy for operable breast cancer with medroxyprogesterone acetate alone in postmenopausal patients or in combination with CMF in premenopausal patients.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Methotrexate; Middle Aged; Prospective Studies; Recurrence | 1988 |
Comparison of lipid and androgen levels after conjugated estrogen or depo-medroxyprogesterone acetate treatment in postmenopausal women.
Topics: Adult; Aged; Androgens; Cholesterol, HDL; Cholesterol, LDL; Estrogens, Conjugated (USP); Female; Humans; Lipids; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Triglycerides | 1985 |
Estrogen and progestin effects on urinary calcium and calciotropic hormones in surgically-induced postmenopausal women.
Topics: Adult; Calcifediol; Calcitonin; Calcitriol; Calcium; Estradiol; Estrogens; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Parathyroid Hormone; Progestins | 1985 |
Efficacy of a continuous estrogen-progestin regimen in the menopausal patient.
Topics: Aged; Climacteric; Drug Therapy, Combination; Endometrium; Estrogens; Female; Humans; Lipoproteins; Medroxyprogesterone; Menopause; Middle Aged; Random Allocation | 1987 |
Metastatic pattern and response to endocrine therapy in human breast cancer.
Topics: Aminoglutethimide; Breast Neoplasms; Diethylstilbestrol; Female; Fluoxymesterone; Humans; Medroxyprogesterone; Menopause; Neoplasm Metastasis; Tamoxifen | 1986 |
Oral versus im administration of high-dose medroxyprogesterone acetate in pretreated patients with advanced breast cancer.
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Biological Availability; Breast Neoplasms; Dose-Response Relationship, Drug; Female; Humans; Hydrocortisone; Injections, Intramuscular; Medroxyprogesterone; Menopause; Metabolic Clearance Rate; Middle Aged; Prognosis; Tamoxifen | 1987 |
A clinical trial of aminoglutethimide in advanced postmenopausal breast carcinoma: low response in patients previously treated with medroxyprogesterone.
Topics: Adult; Aged; Aminoglutethimide; Breast Neoplasms; Clinical Trials as Topic; Combined Modality Therapy; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Medroxyprogesterone; Menopause; Middle Aged; Tamoxifen | 1985 |
Chemotherapy versus chemotherapy plus hormonotherapy in postmenopausal advanced breast cancer patients. A randomized trial.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Female; Fluorouracil; Humans; Medroxyprogesterone; Menopause; Methotrexate; Middle Aged; Prognosis; Random Allocation; Tamoxifen; Vincristine | 1985 |
Plasma monoamine oxidase activity in regularly menstruating women and in amenorrheic women receiving cyclic treatment with estrogens and a progestin.
Topics: Adolescent; Adult; Aged; Amenorrhea; Amines; Analysis of Variance; Brain; Catecholamines; Clinical Trials as Topic; Depression; Estrogens, Conjugated (USP); Female; Gonadal Steroid Hormones; Humans; Medroxyprogesterone; Menopause; Menstruation; Middle Aged; Monoamine Oxidase; Toluene; Tranylcypromine; Tyramine | 1971 |
Clinical and cytologic responses of postmenopausal women to estrogen.
Topics: Administration, Oral; Adult; Cell Count; Endometrium; Epithelial Cells; Epithelium; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone; Menopause; Middle Aged; Placebos; Uterine Hemorrhage; Vagina; Vaginal Smears | 1973 |
Continuous cyclic hormonal therapy.
Topics: Aged; Clinical Trials as Topic; Deficiency Diseases; Endometrium; Estrogens; Estrogens, Conjugated (USP); Ethinyl Estradiol; Female; Humans; Male; Medroxyprogesterone; Menopause; Menstruation; Pseudopregnancy | 1974 |
The treatment of the menopause. Experience with a new progestin-estrogen combination.
Topics: Aged; Clinical Trials as Topic; Ethinyl Estradiol; Female; Humans; Medroxyprogesterone; Menopause; Middle Aged | 1968 |
[Clinical trial of a new synthetic estroprogestinic agent in the climacteric and menopause].
Topics: Adult; Aged; Climacteric; Clinical Trials as Topic; Dysautonomia, Familial; Ethinyl Estradiol; Female; Humans; Leukorrhea; Medroxyprogesterone; Menopause; Middle Aged; Progestins; Pruritus Vulvae; Vaginitis | 1970 |
122 other study(ies) available for medroxyprogesterone and Menopause
| Article | Year |
|---|---|
Hormone replacement therapy for chronic tinnitus in menopausal women: Our experience with 13 cases.
Topics: Age Factors; Chronic Disease; Contraceptives, Oral, Synthetic; Estrogens; Estrogens, Conjugated (USP); Female; Hormone Replacement Therapy; Humans; Medroxyprogesterone; Menopause; Middle Aged; Retrospective Studies; Tinnitus | 2017 |
Conjugated equine estrogen and medroxyprogesterone acetate are associated with decreased risk of breast cancer relative to bioidentical hormone therapy and controls.
Topics: Breast Neoplasms; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone; Menopause; Middle Aged | 2018 |
Lung cancer mortality higher in women who used combination hormone therapy.
Topics: Carcinoma, Non-Small-Cell Lung; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Lung Neoplasms; Medroxyprogesterone; Menopause; Middle Aged; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Smoking; United States | 2009 |
HISTOLOGICAL EFFECTS OF PROGESTINS ON HYPERPLASIA AND CARCINOMA IN SITU OF THE ENDOMETRIUM--FURTHER OBSERVATIONS.
Topics: Carcinoma in Situ; Drug Therapy; Endometrial Hyperplasia; Endometrium; Female; Geriatrics; Humans; Hydroxyprogesterones; Hyperplasia; Hysterectomy; Medroxyprogesterone; Menopause; Mestranol; Neoplasms; Norethindrone; Norethynodrel; Pathology; Progestins; Uterine Neoplasms | 1963 |
Effects of hormone replacement therapy on plasma viscosity and Doppler variations in postmenopausal non-smokers and heavy smokers.
Topics: Administration, Cutaneous; Blood Flow Velocity; Blood Viscosity; Cardiovascular Diseases; Endometrium; Estradiol; Estrogen Replacement Therapy; Eye; Female; Humans; Medroxyprogesterone; Menopause; Middle Aged; Smoking; Thromboxane B2; Ultrasonography, Doppler; Urinary Bladder | 2005 |
[High-dose gestagen therapy with medroxyprogesterone acetate in metastasizing breast carcinoma].
Topics: Administration, Oral; Breast Neoplasms; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Neoplasm Metastasis; Tablets | 1983 |
[Oral high-dose medroxyprogesterone acetate (MPA) in the treatment of advanced and recurrent breast cancer: a dose-response evaluation].
Topics: Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Neoplasm Recurrence, Local | 1982 |
Steroid receptors and response of ovarian cancer to hormones in vitro.
Topics: Adult; Aged; Antineoplastic Agents; Cell Survival; Cells, Cultured; Cystadenocarcinoma; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Ovarian Neoplasms; Receptors, Estrogen; Receptors, Progesterone; Receptors, Steroid; Tamoxifen | 1984 |
Estrogen-progestin pharmacodynamics of the postmenopausal endometrium studied by thymidine labeling.
Topics: Autoradiography; Biopsy; Cell Division; Endometrium; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Thymidine; Tritium | 1982 |
Prolactin: effects of age, menopausal status, and exogenous hormones.
Topics: Adult; Aging; Castration; Estradiol; Estrogens, Conjugated (USP); Female; Gonadal Steroid Hormones; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Prolactin | 1982 |
Mechanisms of uterine bleeding in postmenopausal patients receiving estrogen alone or with a progestin.
Topics: Adult; Drug Therapy, Combination; Endometrium; Estrogens, Conjugated (USP); Female; Histocytochemistry; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Microscopy, Electron; Middle Aged; Norethindrone; Norethindrone Acetate; Substance Withdrawal Syndrome; Uterine Hemorrhage | 1983 |
Oestrogen--progestin therapy and the lipid balance of post-menopausal women.
Topics: Cholesterol; Drug Therapy, Combination; Estrogens, Conjugated (USP); Female; Humans; Lipids; Lipoproteins; Medroxyprogesterone; Menopause; Middle Aged; Triglycerides | 1982 |
Hormones and risk of breast cancer.
Topics: Adult; Breast Diseases; Breast Neoplasms; Estrogens, Conjugated (USP); Female; Follow-Up Studies; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Pain; Risk; Thermography | 1983 |
Differential regulation of alpha-adrenergic receptor subclasses by gonadal steroids in human myometrium.
Topics: Binding, Competitive; Estradiol; Estrogens; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Menstruation; Myometrium; Prazosin; Pregnancy; Progesterone; Receptors, Adrenergic, alpha; Stereoisomerism; Yohimbine | 1983 |
GnRH-test after high-dose MPA in women with post-menopausal LH-preferential release.
Topics: Female; Gonadotropin-Releasing Hormone; Humans; Luteinizing Hormone; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Pituitary Gland; Receptors, Cell Surface; Receptors, LH; Stimulation, Chemical; Time Factors | 1983 |
Depo-medroxyprogesterone acetate compared with conjugated estrogens for the treatment of postmenopausal women.
Topics: Adult; Calcium; Creatinine; Delayed-Action Preparations; Estradiol; Estrogens, Conjugated (USP); Estrone; Female; Humans; Hydroxyproline; Immunosuppressive Agents; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Random Allocation | 1984 |
Adrenal suppression by oral high-dose medroxyprogesterone acetate in breast cancer patients.
Topics: Adrenocorticotropic Hormone; Aged; Androstenedione; Breast Neoplasms; Dehydroepiandrosterone; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Pituitary Hormones | 1984 |
Use of the progestogen challenge test to reduce the risk of endometrial cancer.
Topics: Adenocarcinoma; Aged; Endometrial Hyperplasia; Estrogens; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Precancerous Conditions; Progesterone; Prospective Studies; Risk; Uterine Neoplasms | 1980 |
On the mechanism of action of progestins.
Topics: Castration; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Luteinizing Hormone; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Norethindrone; Pituitary Gland; Progesterone; Progesterone Congeners; Receptors, Androgen | 1981 |
Effect of medroxyprogesterone acetate and d-norgestrel on plasma renin activity, antidiuretic hormone, and urinary aldosterone in postmenopausal women.
Topics: Aged; Aldosterone; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Norgestrel; Renin; Time Factors; Vasopressins | 1981 |
Mechanism of action of contraceptive synthetic progestins.
Topics: Androgen-Insensitivity Syndrome; Animals; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Norethindrone; Ovary; Rabbits; Rats; Receptors, Steroid; Sheep | 1981 |
Female sex steroid receptors in post menopausal endometrial carcinoma. Biochemical responses to antiestrogen and progestin.
Topics: Adenocarcinoma; Animals; Chickens; DNA Polymerase II; Female; Humans; Medroxyprogesterone; Menopause; Oviducts; Progesterone; Prognosis; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen; Uterine Neoplasms | 1984 |
Effect of medroxyprogesterone acetate on serum levels of LH, FSH, cortisol, and estrone in patients with endometrial carcinoma.
Topics: Adenocarcinoma; Aged; Castration; Estrone; Female; Follicle Stimulating Hormone; Humans; Hydrocortisone; Hysterectomy; Luteinizing Hormone; Medroxyprogesterone; Menopause; Middle Aged; Postoperative Care; Uterine Neoplasms | 1981 |
Effect of ovarian steroids on vasopressin secretion.
Topics: Animals; Arginine Vasopressin; Estradiol; Estrogens; Estrus; Female; Humans; Medroxyprogesterone; Menopause; Middle Aged; Pregnancy; Progesterone | 1982 |
The menopause.
Topics: Adult; Aging; Arteriosclerosis; Calcium; Climacteric; Estrogens; Female; Humans; Medroxyprogesterone; Menopause; Middle Aged; Osteoporosis | 1982 |
Circadian pattern of prolactin secretion in postmenopausal women receiving estrogen with or without progestin.
Topics: Circadian Rhythm; Drug Therapy, Combination; Ethinyl Estradiol; Female; Humans; Medroxyprogesterone; Menopause; Middle Aged; Prolactin | 1982 |
Effects of progestins on bone metabolism in postmenopausal women.
Topics: Administration, Oral; Bone and Bones; Calcium; Creatinine; Dose-Response Relationship, Drug; Double-Blind Method; Estradiol; Female; Humans; Hydroxyproline; Medroxyprogesterone; Megestrol; Menopause; Random Allocation | 1982 |
[Medroxyprogesterone acetate in the treatment of postmenopausal syndrome].
Topics: Aged; Female; Humans; Medroxyprogesterone; Menopause; Middle Aged | 1980 |
Metabolic response to starvation. II. Effects of sex steroid administration to pre- and postmenopausal women.
Topics: Adult; Alanine; Contraceptives, Oral, Combined; Estradiol; Fatty Acids, Nonesterified; Female; Humans; Hydroxybutyrates; Ketone Bodies; Kinetics; Medroxyprogesterone; Menopause; Middle Aged; Starvation | 1981 |
Effects of different progestogens on lipoproteins during postmenopausal replacement therapy.
Topics: Cholesterol; Drug Administration Schedule; Estradiol; Female; Humans; Lipoproteins; Lipoproteins, HDL; Lipoproteins, LDL; Medroxyprogesterone; Menopause; Middle Aged; Norethindrone; Norgestrel; Progesterone Congeners | 1981 |
Use of menopausal estrogens and medroxyprogesterone in the United States, 1982-1992.
Topics: Administration, Cutaneous; Administration, Intravaginal; Administration, Oral; Adult; Aged; Aged, 80 and over; Androgens; Drug Prescriptions; Drug Therapy, Combination; Estradiol; Estrogens, Conjugated (USP); Estrone; Female; Humans; Injections, Intramuscular; Medroxyprogesterone; Menopause; Middle Aged; United States | 1995 |
Left ventricular diastolic function by Doppler echocardiography in relation to hormonal replacement therapy in healthy postmenopausal women.
Topics: Alcohol Drinking; Blood Flow Velocity; Body Mass Index; Diastole; Echocardiography, Doppler; Estradiol; Estrogen Replacement Therapy; Female; Heart Rate; Humans; Levonorgestrel; Medroxyprogesterone; Menopause; Middle Aged; Reference Values; Ventricular Function, Left | 1993 |
Endometrial cytology in postmenopausal hormone replacement therapy.
Topics: Adult; Aged; Cell Nucleus; Cytodiagnosis; Drug Administration Schedule; Drug Therapy, Combination; Endometrial Hyperplasia; Endometrium; Epithelial Cells; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone; Menopause; Middle Aged; Norethindrone | 1998 |
Development of a model system for evaluation of human endothelial cell proliferation in vitro: possible clinical applications.
Topics: Cell Culture Techniques; Cell Division; Drug Combinations; Endothelium, Vascular; Estradiol; Female; Hormone Replacement Therapy; Humans; Medroxyprogesterone; Menopause | 2000 |
Effects of hormone replacement therapy on endocrine and spirometric parameters in asthmatic postmenopausal women.
Topics: Administration, Cutaneous; Asthma; Cross-Sectional Studies; Dehydroepiandrosterone Sulfate; Estradiol; Female; Hormone Replacement Therapy; Humans; Hydrocortisone; Medroxyprogesterone; Menopause; Middle Aged; Spirometry | 2001 |
The influence of apo E phenotypes on the plasma triglycerides response to hormonal replacement therapy during the menopause.
Topics: Administration, Cutaneous; Administration, Oral; Adult; Apolipoproteins E; Cardiovascular Diseases; Cholesterol; Cholesterol, HDL; Cohort Studies; Estradiol; Female; Hormone Replacement Therapy; Humans; Medroxyprogesterone; Menopause; Middle Aged; Phenotype; Prospective Studies; Spain; Triglycerides; White People | 2001 |
[Positive effects of estrogens on cardiovascular health].
Topics: Aged; Cardiovascular Diseases; Estradiol; Estrogen Replacement Therapy; Female; Hormone Replacement Therapy; Humans; Medroxyprogesterone; Menopause; Middle Aged; Progesterone Congeners; Randomized Controlled Trials as Topic | 2002 |
Premature menopause: a reversible entity?
Topics: Adult; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone; Menopause; Menopause, Premature; Ovulation; Pregnancy | 1979 |
The effects of cyclical oestrogen therapy and sequential oestrogen/progestogen therapy on the endometrium of postmenopausal women.
Topics: Endometrium; Estrogens; Female; Follow-Up Studies; Humans; Hyperplasia; Medroxyprogesterone; Menopause; Norethindrone; Uterine Hemorrhage; Uterine Neoplasms; Vacuum Curettage | 1977 |
[High-dosage gestagen treatment in the therapy of advanced breast cancer].
Topics: Breast Neoplasms; Drug Evaluation; Female; Humans; Medroxyprogesterone; Menopause; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Time Factors | 1979 |
[Modern prospects in the treatment of cancer of the breast and its metastasis. Medroxyprogesterone in massive doses as an alternative to polychemotherapy].
Topics: Bone Neoplasms; Breast Neoplasms; Drug Therapy, Combination; Female; Hormones; Humans; Medroxyprogesterone; Menopause; Middle Aged; Neoplasm Metastasis | 1977 |
Behavioral effects of estrogen in the human female.
Topics: Behavior; Cell Differentiation; Child; Contraceptive Agents, Female; Double-Blind Method; Estrogens; Female; Fetus; Humans; Maternal-Fetal Exchange; Medroxyprogesterone; Menopause; Menstruation; Pregnancy; Progestins; Thyroid Hormones | 1978 |
[Treatment of the climacteric syndrome with medroxyprogesterone].
Topics: Adult; Drug Evaluation; Female; Humans; Medroxyprogesterone; Menopause; Menstruation; Middle Aged | 1976 |
[Endometrial adenomatous hyperplasia. Analysis of the karyometric variations caused by medorxyprogesterone acetate].
Topics: Adenoma; Adult; Aged; Endometrial Hyperplasia; Endometrium; Epithelial Cells; Epithelium; Female; Humans; Karyometry; Medroxyprogesterone; Menopause; Menstruation; Middle Aged | 1976 |
The influence of hormonal contraceptives on sex hormone binding globulin (SHBG) capacity.
Topics: Adolescent; Adult; Drug Combinations; Ethinyl Estradiol; Female; Gonadal Steroid Hormones; Humans; Lynestrenol; Male; Medroxyprogesterone; Megestrol; Menopause; Middle Aged; Norgestrel; Pregnancy; Pregnancy Trimester, First; Pregnancy Trimester, Second; Pregnancy Trimester, Third; Progesterone Congeners; Protein Binding; Serum Globulins | 1975 |
Estrogens and vitamin B6.
Topics: Adolescent; Adult; Contraceptives, Oral; Contraceptives, Oral, Synthetic; Estrogens; Female; Humans; Medroxyprogesterone; Menopause; Middle Aged; Pyridoxine; Xanthurenates | 1975 |
[Successful treatment of disseminated breast cancer with combination therapy of 5'-deoxy-5'-fluorouridine (5'-DFUR), medroxyprogesterone acetate (MPA) and cyclophosphamide (CPA)].
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Papillary; Cyclophosphamide; Drug Administration Schedule; Female; Floxuridine; Humans; Liver Neoplasms; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Pleural Neoplasms; Soft Tissue Neoplasms | 1992 |
Gonadotropin, steroid, and inhibin levels in women with incipient ovarian failure during anovulatory and ovulatory rebound cycles.
Topics: Adult; Anovulation; Desogestrel; Estradiol; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Follicle Stimulating Hormone; Humans; Infertility, Female; Inhibins; Luteinizing Hormone; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Norgestrel; Norpregnenes; Ovarian Diseases; Ovulation; Progesterone; Progestins | 1991 |
[The elevation of serum iron level with oral administration of medroxyprogesterone acetate (MPA) in patients with breast cancer].
Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Humans; Iron; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Retrospective Studies; Tegafur; Uracil | 1991 |
"Mad pursuits"--markers of cell activity?
Topics: Biomarkers; Biopsy; Delayed-Action Preparations; Endometrium; Estradiol; Estrogen Replacement Therapy; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Pregnancy Proteins | 1991 |
Bone density in women receiving depot medroxyprogesterone acetate for contraception.
Topics: Absorptiometry, Photon; Adult; Body Mass Index; Bone Density; Contraceptive Agents, Female; Delayed-Action Preparations; Female; Femur Neck; Humans; Lumbar Vertebrae; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Osteoporosis; Risk Factors; Smoking; Time Factors | 1991 |
Moderate exercise does not enhance the positive effect of estrogen on bone mineral density in postmenopausal women.
Topics: Bone Density; Estradiol; Estradiol Congeners; Exercise; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Osteoporosis, Postmenopausal; Prospective Studies | 1991 |
Response of carpal tunnel syndrome to hormone replacement therapy.
Topics: Carpal Tunnel Syndrome; Delayed-Action Preparations; Estrogen Replacement Therapy; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged | 1991 |
Transdermal estrogen therapy in menopause. Eighteen months follow-up.
Topics: Administration, Cutaneous; Adult; Blood Pressure; Body Weight; Bone Density; Drug Therapy, Combination; Estradiol; Estrogen Replacement Therapy; Female; Humans; Lipids; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged | 1991 |
Mammographic changes associated with postmenopausal hormone replacement therapy: a longitudinal study.
Topics: Adult; Aged; Breast; Delayed-Action Preparations; Estradiol; Estrogen Replacement Therapy; Female; Follow-Up Studies; Humans; Longitudinal Studies; Mammography; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Retrospective Studies; X-Ray Intensifying Screens | 1990 |
Inability of medroxyprogesterone acetate to down regulate estrogen receptor level in human breast cancer.
Topics: Antineoplastic Agents; Breast Neoplasms; Down-Regulation; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Receptors, Estrogen; Receptors, Progesterone | 1990 |
[Hormonal control of disseminated breast cancer].
Topics: Aminoglutethimide; Antineoplastic Agents; Breast Neoplasms; Delayed-Action Preparations; Estrogen Antagonists; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Neoplasm Metastasis; Tamoxifen | 1990 |
The histochemistry of oestradiol-17 beta dehydrogenase in normal endometrium and endometrial carcinoma: a test to predict the sensitivity of endometrial carcinoma to progestogens: a preliminary report.
Topics: 17-Hydroxysteroid Dehydrogenases; Endometrium; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Uterine Neoplasms | 1990 |
[Effect of medroxyprogesterone acetate on the cell kinetics in primary breast cancer].
Topics: Antineoplastic Agents; Breast Neoplasms; Cell Cycle; DNA, Neoplasm; Female; Flow Cytometry; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Pituitary Hormones, Anterior; Receptors, Estrogen; Receptors, Progesterone | 1990 |
The effect of low-dose estrogen and progestogen on menopausal symptoms and urinary excretion of calcium.
Topics: Adult; Calcium; Creatinine; Estrogen Replacement Therapy; Ethinyl Estradiol; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged | 1990 |
Hormone replacement therapy and lipoprotein changes during early menopause.
Topics: Adult; Cholesterol, HDL; Cholesterol, LDL; Cohort Studies; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Follow-Up Studies; Humans; Lipoproteins; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Multivariate Analysis; Risk Factors; Time Factors | 1990 |
Influence of aminoglutethimide on the metabolism of medroxyprogesterone acetate and megestrol acetate in postmenopausal patients with advanced breast cancer.
Topics: Administration, Oral; Aged; Aminoglutethimide; Breast Neoplasms; Drug Interactions; Female; Humans; Injections, Intravenous; Medroxyprogesterone; Megestrol; Megestrol Acetate; Menopause; Middle Aged; Progestins | 1990 |
Evaluation of a continuous combined low-dose regimen of estrogen-progestin for treatment of the menopausal patient.
Topics: Cholesterol; Drug Therapy, Combination; Estrogen Replacement Therapy; Estrogens; Female; Humans; Lipoproteins; Medroxyprogesterone; Menopause; Middle Aged; Patient Compliance; Triglycerides; Uterine Hemorrhage | 1990 |
A simple way to manage menopause.
Topics: Aged; Calcitonin; Calcium; Climacteric; Endometrial Hyperplasia; Estrogen Replacement Therapy; Female; Humans; Medroxyprogesterone; Menopause; Middle Aged; Osteoporosis; Physical Exertion; Risk Factors | 1990 |
Ovarian steroid treatment blocks a postmenopausal increase in blood monocyte interleukin 1 release.
Topics: Adult; Cells, Cultured; Delayed-Action Preparations; Estrogens; Female; Humans; Interleukin-1; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Monocytes; Osteoporosis; Reference Values; Regression Analysis | 1989 |
High-dose medroxyprogesterone acetate in advanced breast cancer. Clinical and pharmacokinetic study with a combined oral and intramuscular regimen.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Bone Neoplasms; Breast Neoplasms; Drug Administration Schedule; Drug Evaluation; Female; Humans; Injections, Intramuscular; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged | 1989 |
Influence of tamoxifen-medroxyprogesterone sequential therapy on estrogen and progesterone receptor contents of breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cell Nucleus; Cytosol; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen | 1989 |
Postmenopausal endometriosis associated with hormone replacement therapy. A case report.
Topics: Endometriosis; Estrogens; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Peritoneal Neoplasms | 1989 |
[Initial experience with centralized care of women with bleeding in the climacteric and postmenopausal period].
Topics: Climacteric; Endometrium; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Uterine Hemorrhage | 1989 |
Sequential cyclic combined hormonal therapy for metastatic breast cancer.
Topics: Adult; Aged; Breast Neoplasms; Ethinyl Estradiol; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Neoplasm Metastasis; Receptors, Estrogen; Receptors, Progesterone | 1989 |
Menopausal hormone replacement therapy with continuous daily oral micronized estradiol and progesterone.
Topics: Cholesterol; Climacteric; Delayed-Action Preparations; Drug Administration Schedule; Drug Combinations; Estradiol; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Pilot Projects; Progesterone | 1989 |
[Current status of hormonotherapy of metastatic cancer of the breast].
Topics: Aminoglutethimide; Androgens; Breast Neoplasms; Estrogens; Female; Humans; Hydrocortisone; Medroxyprogesterone; Menopause; Ovariectomy; Tamoxifen | 1989 |
Clinical and metabolic responses of menopausal women to sequential versus continuous estrogen and progestin replacement therapy.
Topics: Biopsy; Cholesterol; Drug Administration Schedule; Drug Therapy, Combination; Endometrium; Estrogens, Conjugated (USP); Female; Humans; Lipids; Lipoproteins; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged | 1988 |
Continuous estrogen/progestin therapy in menopause.
Topics: Biopsy; Blood Pressure; Cholesterol, HDL; Cholesterol, LDL; Endometrium; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Menstruation; Middle Aged; Time Factors; Triglycerides | 1987 |
The post-menopausal uterus: the effect of hormone replacement therapy on the serum levels of secretory endometrial protein PP14/beta-lactoglobulin homologue.
Topics: Estradiol; Estrogens, Conjugated (USP); Female; Glycodelin; Glycoproteins; Humans; Hysterectomy; Medroxyprogesterone; Menopause; Middle Aged; Pregnancy Proteins | 1987 |
Sequential use of conjugated estrogens and medroxyprogesterone in the climacteric syndrome: clinical and histological findings.
Topics: Adult; Climacteric; Drug Administration Schedule; Drug Evaluation; Drug Therapy, Combination; Endometrium; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged | 1988 |
The effects of medroxyprogesterone acetate on enzyme activities in human endometrial carcinoma.
Topics: Creatine Kinase; Cytosol; Enzyme Activation; Female; Glucosephosphate Dehydrogenase; Humans; Isocitrate Dehydrogenase; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Receptors, Estrogen; Receptors, Progesterone; Uterine Neoplasms | 1985 |
Modalities and results of a combined anti-estrogenic therapy by means of tamoxifen and medroxyprogesterone in gynecologic cancerology.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Drug Administration Schedule; Female; Humans; Lymphatic Metastasis; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Neoplasms, Hormone-Dependent; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen; Uterine Hemorrhage; Uterine Neoplasms | 1986 |
Interactions of medroxyprogesterone acetate with estrogen on the calcium-parathyroid axis in post-menopausal women.
Topics: Adult; Aged; Calcium; Drug Therapy, Combination; Estrogens; Female; Humans; Hydroxyproline; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Parathyroid Hormone | 1986 |
Pharmacokinetics of progestational compounds.
Topics: Absorption; Aged; Blood Proteins; Drug Interactions; Female; Humans; Kinetics; Levonorgestrel; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Norethindrone; Norgestrel; Osmolar Concentration; Progestins | 1986 |
Aminoglutethimide and medroxyprogesterone acetate in the treatment of patients with advanced breast cancer. A phase II study of the Association of Medical Oncology of the German Cancer Society (AIO).
Topics: Adult; Aged; Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Drug Evaluation; Drug Synergism; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Neoplasm Metastasis; Pain | 1986 |
Assessment of the potency of orally administered progestins in women.
Topics: Administration, Oral; Adult; Age Factors; DNA; Dose-Response Relationship, Drug; Drug Evaluation; Dydrogesterone; Endometrium; Estradiol Dehydrogenases; Female; Glycogen; Humans; Isocitrate Dehydrogenase; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Menstrual Cycle; Middle Aged; Norethindrone; Norgestrel; Progesterone; Progesterone Congeners; Reference Values | 1986 |
The effects of low and high dose medroxyprogesterone acetate on sex steroids and sex hormone binding globulin in postmenopausal breast cancer patients.
Topics: Androstenedione; Antineoplastic Agents; Breast Neoplasms; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Estradiol; Estrone; Female; Gonadal Steroid Hormones; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Sex Hormone-Binding Globulin; Testosterone | 1987 |
Phase II evaluation of oral medroxyprogesterone acetate in advanced breast cancer: a Northern California Oncology Group Study.
Topics: Adult; Aged; Breast Neoplasms; Drug Evaluation; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged | 1987 |
Sequential combination of tamoxifen and high dose medroxyprogesterone acetate: therapeutic and endocrine effects in postmenopausal advanced breast cancer patients.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Drug Evaluation; Female; Hormones; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Prognosis; Tamoxifen | 1987 |
Medroxyprogesterone acetate at very high doses in postmenopausal advanced breast cancer patients.
Topics: Adult; Aged; Antineoplastic Agents; Bone Neoplasms; Breast Neoplasms; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Remission Induction | 1987 |
[Effects of high-dose medroxyprogesterone acetate in advanced breast cancer, with special reference to prior endocrine therapy and hormone receptors].
Topics: Administration, Oral; Aged; Breast Neoplasms; Estrogen Antagonists; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Prognosis; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen | 1988 |
Sex steroids modulate prolactin response to naloxone in postmenopausal women.
Topics: Endorphins; Estradiol; Estrogens, Conjugated (USP); Estrone; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Medroxyprogesterone; Menopause; Middle Aged; Naloxone; Pituitary Gland, Anterior; Prolactin | 1985 |
Biochemical and histologic effects of sequential estrogen/progestin therapy on the endometrium of postmenopausal women.
Topics: Biopsy; Cytosol; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Therapy, Combination; Endometrium; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Receptors, Estrogen | 1986 |
Is Provera the ideal progestogen for addition to postmenopausal estrogen therapy?
Topics: Biopsy; Delayed-Action Preparations; DNA; Dose-Response Relationship, Drug; Endometrium; Estradiol Dehydrogenases; Estrogens, Conjugated (USP); Female; Humans; Isocitrate Dehydrogenase; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Microscopy, Electron; Receptors, Estradiol | 1986 |
The effect of estrogen-progestin treatment on opioid control of gonadotropin and prolactin secretion in postmenopausal women.
Topics: Drug Therapy, Combination; Endorphins; Estrogens, Conjugated (USP); Female; Gonadotropins, Pituitary; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Naloxone; Prolactin | 1986 |
Progestational agents in advanced breast cancer: an overview.
Topics: Antineoplastic Agents; Breast Neoplasms; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Menopause; Neoplasm Metastasis; Neoplasm Staging; Neoplasms, Hormone-Dependent; Prognosis; Receptors, Cell Surface; Tamoxifen | 1986 |
Treatment of postmenopausal osteoporosis.
Topics: Calcium; Drug Therapy, Combination; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone; Menopause; Osteoporosis | 1987 |
Influence on blood pressure of oestrogen substitution therapy in the menopause.
Topics: Aged; Blood Pressure; Estradiol; Estriol; Estrogens; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Retrospective Studies | 1987 |
Ovulation after treatment with ethinyl-oestradiol and medroxyprogesterone acetate in a woman approaching premature menopause. Case report.
Topics: Adult; Drug Therapy, Combination; Estradiol; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Humans; Infertility, Female; Luteinizing Hormone; Medroxyprogesterone; Menopause; Menopause, Premature; Ovulation Induction; Progesterone; Ultrasonography | 1986 |
Progestins increase endogenous opioid peptide activity in postmenopausal women.
Topics: Aged; Endorphins; Estradiol; Estrone; Female; Humans; Luteinizing Hormone; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Naloxone; Progestins; Prolactin | 1985 |
Influence of aminoglutethimide on plasma levels of medroxyprogesterone acetate: its correlation with serum cortisol.
Topics: Aminoglutethimide; Breast Neoplasms; Drug Therapy, Combination; Female; Humans; Hydrocortisone; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Neoplasm Metastasis; Pilot Projects | 1985 |
[Changes in serum lipoproteins under hormonal therapy of breast carcinoma and other endocrine-dependent tumors].
Topics: Aminoglutethimide; Breast Neoplasms; Cholesterol; Cortisone; Drug Therapy, Combination; Female; Humans; Lipoproteins; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Neoplasm Metastasis; Neoplasms, Hormone-Dependent; Triglycerides | 1985 |
[Therapeutic effects of medroxyprogesterone acetate in recurrent or advanced breast cancer].
Topics: Administration, Oral; Adult; Aged; Body Weight; Breast Neoplasms; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Neoplasm Recurrence, Local | 1985 |
Prolactin levels and hormonal profile in postmenopausal patients with advanced breast cancer during endocrine treatments.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Bromocriptine; Delayed-Action Preparations; Estradiol; Female; Gonadotropins, Pituitary; Hormones; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Prolactin; Tamoxifen; Testosterone; Thyroid Hormones | 1985 |
Some anthropological aspects of the climacteric syndrome.
Topics: Climacteric; Drug Therapy, Combination; Estradiol; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Time Factors | 1985 |
Serum levels of human chorionic gonadotropin in nonpregnant women and men are modulated by gonadotropin-releasing hormone and sex steroids.
Topics: Adult; Aged; Chorionic Gonadotropin; Chromatography, Gel; Estradiol; Female; Gonadal Steroid Hormones; Humans; Immunoassay; Luteinizing Hormone; Male; Medroxyprogesterone; Menopause; Middle Aged; Pituitary Hormone-Releasing Hormones | 1987 |
Decrease of granulocyte-macrophage colony-forming units during high dose medroxyprogesterone acetate treatment in advanced breast cancer.
Topics: Breast Neoplasms; Colony-Forming Units Assay; Female; Granulocytes; Humans; Leukocyte Count; Macrophages; Medroxyprogesterone; Menopause; Time Factors | 1985 |
Subfractions of high-density lipoprotein cholesterol during estrogen replacement therapy: a comparison between progestogens and natural progesterone.
Topics: Aged; Apolipoproteins A; Cholesterol, HDL; Estrogens; Female; Humans; Medroxyprogesterone; Menopause; Middle Aged; Norgestrel; Progesterone; Progesterone Congeners | 1985 |
Cyclic hormonetherapy. A report on 305 cases.
Topics: Adult; Aged; Breast Neoplasms; Coronary Disease; Estradiol; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone; Menopause; Middle Aged; Osteoporosis; Uterine Neoplasms; Vaginal Smears | 1966 |
Post menopausal bleeding related to estrogen therapy. An increasing problem.
Topics: Curettage; Diethylstilbestrol; Estrogens; Estrogens, Conjugated (USP); Ethinyl Estradiol; Female; Humans; Medroxyprogesterone; Menopause; Methyltestosterone; Uterine Hemorrhage | 1968 |
[The urocytogram in the menopause].
Topics: Atrophy; Endocrine System Diseases; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone; Menopause; Urinary Bladder Diseases; Urine; Vaginal Smears | 1968 |
Cyclic hormone therapy in climacteric and menopausal women in Iran. Report of 600 cases.
Topics: Adult; Climacteric; Estrogens; Estrogens, Conjugated (USP); Ethynodiol Diacetate; Female; Humans; Iran; Medroxyprogesterone; Menopause; Mestranol; Middle Aged; Progesterone; Progestins | 1971 |
The climacteric.
Topics: Adolescent; Adult; Age Factors; Aged; Blood Pressure; Castration; Climacteric; Endometrial Hyperplasia; Estradiol; Estrogens; Estrogens, Conjugated (USP); Female; Humans; Hysterectomy; Libido; Male; Medroxyprogesterone; Menopause; Methyltestosterone; Middle Aged; Norethindrone; Osteoporosis; Progesterone | 1973 |
[Substitution therapy with equiline sulfate in menopausal women].
Topics: 17-Ketosteroids; Estranes; Estrogens, Conjugated (USP); Female; Humans; Hydroxysteroids; Medroxyprogesterone; Menopause | 1973 |
Gynecologic endocrine disorders in childhood and adolescence.
Topics: Adolescent; Adrenal Gland Neoplasms; Adrenal Hyperplasia, Congenital; Cerebral Ventricle Neoplasms; Child; Child, Preschool; Cortisone; Endocrine System Diseases; Female; Fibrous Dysplasia of Bone; Granulosa Cell Tumor; Humans; Infant, Newborn; Medroxyprogesterone; Menopause; Menstruation Disturbances; Ovarian Cysts; Ovarian Neoplasms; Pigmentation Disorders; Progesterone; Puberty, Precocious; Sertoli-Leydig Cell Tumor; Sex Chromosome Aberrations; Turner Syndrome; Vaginal Smears; Virilism | 1973 |
Quantitative relationships of the pituitary-gonadal axis in postmenopausal women.
Topics: Aged; Clomiphene; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Medroxyprogesterone; Menopause; Middle Aged | 1973 |
Scanning electron microscopic study of the human fallopian tube report. IV. At term gestation and in the puerperium. The effect of a synthetic progestin on the postmenopausal tube.
Topics: Epithelial Cells; Epithelium; Fallopian Tubes; Female; Humans; Medroxyprogesterone; Menopause; Microscopy, Electron, Scanning; Postpartum Period; Pregnancy; Time Factors; Urinary Incontinence; Uterine Prolapse | 1973 |
Effect of oophorectomy on circulating testosterone and androstenedione levels in patients with endometrial cancer.
Topics: Adenocarcinoma; Adult; Aged; Androstenedione; Castration; Curettage; Estrogens; Fallopian Tubes; Female; Humans; Hysterectomy; Medroxyprogesterone; Menopause; Metabolic Clearance Rate; Middle Aged; Ovary; Radioimmunoassay; Testosterone; Uterine Neoplasms | 1974 |
Full replacement therapy of the menopause.
Topics: Blood Platelets; Blood Pressure; Body Weight; Cholesterol; Ethinyl Estradiol; Female; Hemoglobins; Humans; Leukocyte Count; Medroxyprogesterone; Menopause; Middle Aged; Nausea; Vaginal Smears | 1972 |
Perimenopausal patients: treatment with continual escalating-dose synthetic estrogen with added progestogen.
Topics: Adult; Aged; Biopsy; Climacteric; Endometrium; Ethinyl Estradiol; Female; Humans; Medroxyprogesterone; Menopause; Menstruation Disturbances; Middle Aged; Time Factors; Vaginal Smears | 1972 |
Management of the climacteric and postmenopausal woman.
Topics: Aged; Anxiety; Climacteric; Coronary Disease; Depression; Estrogens; Female; Humans; Medroxyprogesterone; Menopause; Middle Aged; Neoplasms; Osteoporosis; Ovary; Psychophysiologic Disorders; Vaginitis; Vasomotor System | 1972 |
[Sequential triphasic therapy in the menopause].
Topics: Adult; Ethinyl Estradiol; Female; Genital Diseases, Female; Humans; Hysterectomy; Medroxyprogesterone; Menopause; Middle Aged | 1969 |
Amenorrhea.
Topics: Adolescent; Adrenal Hyperplasia, Congenital; Adult; Amenorrhea; Androgen-Insensitivity Syndrome; Central Nervous System Diseases; Congenital Abnormalities; Contraceptives, Oral; Diagnosis, Differential; Disorders of Sex Development; Female; Humans; Lactation; Medroxyprogesterone; Menopause; Mullerian Ducts; Nutrition Disorders; Polycystic Ovary Syndrome; Pregnancy; Puberty; Substance Withdrawal Syndrome; Turner Syndrome | 1969 |
[Treatment of the preclimacteric and climacteric with a new estrogen-progestin association].
Topics: Carbohydrate Metabolism; Depression; Dysautonomia, Familial; Estrogens; Ethinyl Estradiol; Female; Humans; Hypercholesterolemia; Hypertension; Medroxyprogesterone; Menopause; Middle Aged; Osteoporosis | 1969 |
[Hormones and genital cancer in women].
Topics: Adult; Endometrium; Estrogens; Female; Humans; Medroxyprogesterone; Menopause; Middle Aged; Ovarian Neoplasms; Progesterone; Testosterone; Uterine Cervical Neoplasms; Uterine Neoplasms; Vulvar Neoplasms | 1969 |
[Value of associated estro-progestinic therapy in disorders of the female climacteric and of the post-menopausal period].
Topics: Adult; Aged; Dysautonomia, Familial; Estrogens; Ethinyl Estradiol; Female; Humans; Medroxyprogesterone; Menopause; Middle Aged; Progestins; Pruritus Vulvae; Uterine Prolapse; Vulvar Lichen Sclerosus; Vulvovaginitis | 1970 |